Latest news on Laboratorytalk categorised by supplier
Warnex
Address:
3885 Industriel Blvd
Laval
H7L 4S3
Canada
Our RSS feed for news from Warnex
Request to receive our free email newsletter each week
Listing of all 21 news releases from Warnex:
Prostate cancer screening service now available
The Warnex PCA3 screening service for prostate cancer uses advanced PCR technology to detect mRNA from the prostate cancer gene 3 (PCA3)
News from Warnex ( 7 March 2008)
Licencing Xenomics's acute myeloid leukemia test
Warnex's medical laboratories division now offers NPM1 testing in Canada as a laboratory service for the diagnosis, stratification and monitoring of patients with acute myeloid leukemia (AML)
News from Warnex ( 3 March 2008)
Warnex's to continue laboratory services business
Warnex's board of directors has concluded that at the present time, the option which provides the most value for its shareholders is the continued operation of its laboratory services business
News from Warnex ( 6 February 2008)
Bioavailable testosterone testing services deal
User application article The bioavailable testosterone test is a diagnostic test recommended for male patients in evaluating a condition known as andropause
News from Warnex (21 September 2007)
Warnex to market a leukemia diagnostic service
Warnex has announced an exclusive agreement with Ipsogen SAS, a company committed to developing tests to improve the disease management of cancer patients
News from Warnex (15 August 2007)
Warnex pathogen detection business sold to AES
Warnex has sold the assets of its pathogen detection business to AES Laboratoire, a French manufacturer and supplier of laboratory equipment based in Bruz, France
News from Warnex (10 July 2007)
Warnex "reviewing its strategic options"
Warnex has initiated a review of various strategic options including partnerships, mergers, or the sale of the company, for its ongoing laboratory services business
News from Warnex (27 April 2007)
FDA inspects Warnex's bioanalytical facilities
The FDA inspected and reviewed Warnex's bioanalytical laboratories and its quality control systems, as well as several client-specific studies, during the recent audit
News from Warnex (25 April 2007)
Contract win with Novartis Canada
Warnex will perform pharmacogenetic and bioanalytical services for Novartis Pharmaceuticals Canada's Gleevec monitoring programme
News from Warnex (11 April 2007)
Pharmacogenetic services for Schering-Plough
User application article Warnex announces that its medical laboratories division will develop new pharmacogenetic assays and serve as a central laboratory for several clinical studies of Schering-Plough Canada
News from Warnex (25 January 2007)
NPIP approval for salmonella test
Salmonella test used with the Warnex Rapid Pathogen Detection System has been approved by the US Department of Agriculture's (USDA) National Poultry Improvement Plan (NPIP)
News from Warnex ( 5 October 2006)
Warnex concludes acquisition of MDS Pharma
Warnex Analytical Services has concluded the acquisition of the MDS Pharma Services pharmaceutics business located in Blainville, Quebec, following an agreement in principle announced on 18 July 2006
News from Warnex ( 5 September 2006)
Warnex and Eppendorf form strategic alliance
Warnex has formed a strategic alliance with Eppendor which will combine Mastercycler EP realplex real-time PCR system with pathogen detection kits and software to provide enhanced food safety tests
News from Warnex (15 August 2006)
Warnex poised to double analytical services unit
Warnex has entered into an agreement in principle for the acquisition of the MDS Pharma Services pharmaceutics business located within its Blainville, Quebec facility
News from Warnex (21 July 2006)
AOAC-RI validation for campylobacter test
Quantitative campylobacter test granted Performance Tested status by the AOAC Research Institute and is the first quantitative real-time PCR test available to the food industry to be AOAC-validated
News from Warnex ( 5 June 2006)
Warnex products to be distributed by Foss UK
Warnex has finalised an agreement with Foss UK to distribute and market the Warnex rapid pathogen detection system in the United Kingdom and Ireland
News from Warnex (17 May 2006)
Warnex concludes acquisition of Pro-DNA Diagnostic
Warnex has concluded the acquisition of all of the issued and outstanding shares of Pro-DNA Diagnostic, a laboratory offering genetic testing services, following an agreement announced 25 April 2006
News from Warnex (16 May 2006)
Warnex to buy Pro-DNA Diagnostic Laboratory
Warnex has entered into an agreement in principle for the acquisition of Pro-DNA Diagnostic, a laboratory offering genetic testing services
News from Warnex (28 April 2006)
Warnex signs up Jem Analytical Laboratory Services
User application article Warnex announced that Jem Analytical Laboratory Services, Georgia, has purchased a Warnex rapid pathogen detection system to offer real-time PCR pathogen testing services to its customers
News from Warnex (30 March 2006)
Warnex signs up US service lab, AmeriSci Bio-Chem
AmeriSci Bio-Chem, a leading scientific service laboratory based in Midlothian, Virginia, will offer real-time PCR pathogen testing services using the Warnex rapid pathogen detection system
News from Warnex (28 March 2006)
Quantitative PCR test for food testing

